Research on common biomarkers of sarcopenia and cognitive impairment
CSTR:
Author:
Affiliation:

(Department of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China)

Clc Number:

Fund Project:

This work was supported by National Key Research and Development Program of China(2018YFC2002101), and Health Industry Clinical Research Program of Shanghai Municipal Health Commission(202040088).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Sarcopenia and cognitive impairment, two common geriatric syndromes, have mutual causality. Sarcopenia increases the risk of cognitive impairment, and cognitive impairment can also cause sarcopenia, eventually developing into a vicious cycle. Early recognition and intervention of sarcopenia and cognitive impairment are crucial to improve the quality of life of the elderly patients. Biomarkers appear earlier in the body than clinical phenotypes. Therefore, this paper preliminarily discusses the potential common biomarkers of sarcopenia and cognitive impairment from four aspects, including inflammation, hormone, nutrition and growth factors, helping objective and timely identification of individuals with sarcopenia and cognitive impairment.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:June 25,2021
  • Revised:
  • Adopted:
  • Online: June 29,2022
  • Published:
Article QR Code